| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8785630 | Bulletin du Cancer | 2018 | 6 Pages |
Abstract
Treating patients with up to five prostate cancer metastases is efficient and has a low toxicity. Prospective trials should identify which patients, if any, really benefit from this approach.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Jean-Emmanuel Bibault,